Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published online as doi:10.1189/jlb.1104644 on March 23, 2005

Published online before print March 23, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.1104644v1
78/1/144    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mukherjee, S.
Right arrow Articles by Nandi, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mukherjee, S.
Right arrow Articles by Nandi, D.
(Journal of Leukocyte Biology. 2005;78:144-157.)
© 2005 by Society for Leukocyte Biology

CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A

Sambuddho Mukherjee, Asma Ahmed and Dipankar Nandi1

Department of Biochemistry, Indian Institute of Science (IISc), Bangalore, India

1 Correspondence: #126, Department of Biochemistry, Indian Institute of Science, Bangalore, 560012 India. E-mail: nandi{at}biochem.iisc.ernet.in

The mechanisms by which concanavalin A (Con A), a lectin, activates T cells are poorly studied. A low dose of Con A is stimulatory for T cells, whereas a high dose of Con A results in suppression of proliferation and enhanced T cell death. The expression and functional roles of costimulatory receptors, CD28 and cytotoxic T-lymphocyte antigen 4 (CTLA4), and their ligands, CD80 and CD86, on primary mouse CD4+ T cells after activation with different doses of Con A were studied. CTLA4-CD80/CD86 interactions in this T:T cell activation model demonstrate distinct outcomes depending on the dose of Con A. CTLA4-CD80/CD86 interactions inhibit CD4+ T cell cycling and survival after activation with a suppressive dose of Con A by increasing oxidative stress and decreasing levels of BclXL. The enhanced CD4+ T cell death with a suppressive dose of Con A is dependent on excess H2O2 and nitric oxide but is independent of Fas and caspase activity. It is surprising that the increased proliferation of CD4+ T cells with a suppressive dose of Con A on blocking CTLA4-CD80/CD86 interactions is largely interleukin (IL)-2-independent but is cyclosporine A-sensitive. On activation with a stimulatory dose of Con A, CTLA4-CD80/CD86 interactions enhance T cell activation and survival by reducing the production of reactive oxygen species, increasing IL-2 and BclXL levels. Here IL-10 but not transforming growth factor-ß plays a functional role. In summary, CTLA4-CD80/CD86 interactions on T cells integrate signal strength, based on the dose of Con A, to enhance or inhibit primary mouse CD4+ T cell cycling and survival.

Key Words: costimulation • T cell cycling and survival • IL-2-independent • oxidative stress • IL-10 • TGF-ß




This article has been cited by other articles:


Home page
Int ImmunolHome page
S. J. Prasanna, B. Saha, and D. Nandi
Involvement of oxidative and nitrosative stress in modulation of gene expression and functional responses by IFN{gamma}
Int. Immunol., July 2, 2007; (2007) dxm058v1.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Mukherjee, A. Ahmed, S. Malu, and D. Nandi
Modulation of cell cycle progression by CTLA4-CD80/CD86 interactions on CD4+ T cells depends on strength of the CD3 signal: critical role for IL-2
J. Leukoc. Biol., July 1, 2006; 80(1): 66 - 74.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Society for Leukocyte Biology.